NSF and Alzheimer disease: Comparison with differential expression analysis revealed that ATP6V1D, ATP6V1G2, CLTB, and NSF were all downregulated (log2FC < 0) in AD (Table S2) and identified as protective factors against AD in the MR analysis, thereby defining them as potential biomarkers relevant to AD in this study.